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In recent decades, there has been a growing interest in the use of herbs and herbal medicinal 16 
products, both in developing and developed countries.  While electronic medium has become a 17 
more and more important tool for presenting information about health-related issues, several 18 
studies demonstrated that the internet often contains inaccurate and/or misleading information. 19 
In our study we assessed 30 Hungarian websites and 2 cellphone applications intended for 20 
public use and evaluated the quality and credibility of the information presented about 21 
medicinal plants recommended. It was found that websites showed very diverse safety: most 22 
websites gave mixed information, that is, some medicinal herbs and their potential hazard were 23 
properly described while others were not. There were, however, websites which completely 24 
missed to give information about any potential hazard. As credibility of public websites can be 25 
in most cases questioned, it is strongly recommended for potential users to consult more than 26 
one source of information. 27 
 28 




In recent decades, the popularity of herbs and herbal medicinal products has been growing both 33 
in developing and developed countries, including Hungary.  In developed countries, many 34 
patients or consumers are seeking herbal therapy assuming that it will promote healthier living 35 
(Ekor 2014). 36 
However, while there is a quite general belief that herbal medicines are safe because 37 
they are ’natural’ (White et al. 2014), traditional is not necessarily safe. There are numerous 38 
risk factors associated with the use of herbal medicinal products, including unexpected toxicity 39 
(Jordan et al., 2010).  40 
Due to the continuous development of analytical technology, identification and 41 
detection of secondary metabolites have considerably improved (Masullo et al. 2015), revealing 42 
the presence of potentially toxic bioactive compounds such as hepatotoxic pyrrolizidine 43 
alkaloids (PAs) (Kristanc and Kreft 2016a). Wiesner and Knöss (2014) discuss that a complete 44 
chemical profile should be given, including not only the major ingredients but all bioactive 45 
compounds.  46 
Unexpected toxicity also occurs in case of mis-identification (Kristanc and Kreft 47 
2016b), adulteration (Techen et al. 2014) or contamination.  Contamination can be observed in 48 
polluted habitats where the plants accumulate heavy metals and/or polyaromatic hydrocarbons 49 
(PAHs), either from contaminated soil or from atmospheric deposition (reviewed by Tripathy 50 
et al. 2015). Pesticide residues have also been detected (Zhang et al. 2012). Herbs or herbal 51 
preparations can be contaminated with mycotoxins which might cause adverse human health 52 
effects (Ashiq et al. 2014). In some cases, even parasites have been found in herbal preparations 53 
(Mazzanti et al. 2008). Phytochemical variability might also be an issue: chemical composition 54 
and thus mode of action of the plant can be influenced by environmental factors (reviewed by 55 
Dhami and Mishra 2015).  56 
Clinical reports prove that interactions with other drugs, either pharmaceutical or herbal, 57 
can pose actual human health hazard (e.g. Izzo and Ernst 2001, Jordan et al. 2010).  58 
For the public, diverse information sources are available on the collection, cultivation, 59 
identification, mode of action and preparation of herbs. They involve books, websites, lectures 60 
(also accessible on the internet), organised excursions and/or visits to botanical gardens. 61 
Electronic medium has become a more and more important tool for presenting information 62 
about health-related issues, including medicinal plant databases (Ningthoujam et al. 2012). For 63 
example, in the U.S., sixty-one percent of adults seek health information online (Kitchens et al. 64 
2014).  65 
Public websites, however, might lack quality assurance; in other words, the information 66 
provided by them might have been compiled without actual scientific review. Bearing in mind 67 
the growing interest towards herbal medicinal products and the potential hazards mentioned, 68 
the purpose of the study was to evaluate the credibility of readily available Hungarian websites 69 
about medicinal herbs. Another aspect of the evaluation was whether the database included 70 




Google-based search was done, using the selective keywords: medicinal plants; everyday 75 
medicinal plants; common medicinal plants (in Hungarian: gyógynövények; mindennapi 76 
gyógynövények/gyógynövényeink; gyakori gyógynövények). Websites were evaluated in order 77 
of appearance. Exclusion criteria were: 78 
 commercial ads (for example, advertising herbal products, books, training courses, etc.) 79 
 simple compilation of publications 80 
 only a narrow collection of selected herbs, e.g. for losing weight. 81 
Websites were preferred which included a list of recommended medicinal herbs with: 82 
 description (including taxonomy, habitat or other ecological traits) 83 
 information on collection (methods, season, etc.) 84 
 mode of action 85 
 suggested use, mode of preparation  86 
 additional information (e.g. photo, potential risks, etc.). 87 
Websites were evaluated based on: 88 
 number of potentially hazardous plants per website 89 
 number of potentially hazardous plants per website inadequately described  90 
 number of protected species per website 91 
 number of protected species per website inadequately described (the website did not 92 
mention the protected status of the plant and did not inform the users that collection of 93 
any part of the specimen was strictly forbidden by Hungarian national legislation). 94 
Plants included in the list of the (Hungarian) National Institute of Pharmacy and Nutrition 95 
(OÉTI 2013) were considered potentially toxic/hazardous (Table 1). In case of any doubt, 96 
community herbal monographs or public statements (reviewed by Chinou 2014) were 97 
consulted. In case of Fumaria officinalis for example, the OÉTI List states that: ‘not enough 98 
data are available to assess safety’. The Community Monograph (HMPC, 2011a) gives special 99 
warnings and precautions for use, such as contraindications in case of biliary diseases and 100 
hepatitis.   101 
Description was considered safe if the website mentioned the potential toxicity of the herb, 102 
or gave another special warnings, such as potential contraindications, or safe dose (e.g. in case 103 
of Artemisia absinthium a daily intake of 3.0 mg/person is acceptable for a maximum duration 104 
of use of 2 weeks, due to the thujone content (HMPC, 2009).  105 
 Legal status of the species was given according to the 13/2001. (V. 9.) KöM Decree.  106 
 107 
Results  108 
 109 
Altogether 30 websites and 2 cellphone applications were assessed. Table 2 gives a summary 110 
about (1) number of potentially hazardous plants per website; (2) number of potentially 111 
hazardous plants per website with lacking/misleading information about the potential hazards; 112 
(3) number of protected species per website and (4) number of protected species per website 113 
with lacking/misleading information about the legal status. 114 
Considering potential risk of herbs, credibility and safety of websites varied to a high 115 
extent. The lowest category of safety and credibility is represented by websites where no 116 
information was given about potential hazards (e.g. W1, W10 and W11). Most websites gave 117 
mixed information: some medicinal herbs and their potential risks were properly described 118 
while others were not (e.g. W6 which included 23 potentially hazardous species but only 3 were 119 
improperly described or W12 which included 25 potentially hazardous species but gave 120 
inappropriate description for approximately half of them, 13). It is interesting to note that W28 121 
and W29 covered the widest range of potentially hazardous plants (38 and 32, respectively) and 122 
also, number of inappropriately described plants was the highest in their case, 25 and 18, 123 
respectively. Of cellphone applications, the wider database (App1) included 22 potentially 124 
hazardous species but description of only 6 were found as inappropriate. The other included 125 
only 6 such species, but provided correct information on the potential hazard. 126 
Considering the protected status of medicinal herbs, websites also varied to a great 127 
extent. For example, W12 included 16 protected species and 15 were improperly described; 128 
similarly, W28 included 18 protected species and for 17 of them, no information was provided 129 
about the legal status. On the contrary, W29 included 21 protected species and the conservation 130 





As the number of people consulting the Internet in health-related issues is continuously rising, 136 
more and more studies attempt to assess the credibility of websites (e.g.  Lederman et al. 2014, 137 
Gao et al. 2015).  138 
Molassiotis and Xu (2004) evaluated safety issues of web-based information about 139 
herbal medicines in the treatment of cancer. In their study, a scoring system was applied to give 140 
a quantitative estimation about overall safety of the website. They concluded that based on these 141 
scores, ’the safety of the web-based information on herbs in the treatment of cancer was low’. 142 
While in our study commercial websites (advertising some herbal products) were excluded, the 143 
assessment of Molassiotis and Xu included such websites and found that they had the lowest 144 
safety scores.  145 
In parallel with the growing interest in herbal medicinal products, there is an increasing 146 
concern about their safety on institutional level. The World Health Organisation (2004) 147 
recommends the safety monitoring of herbal medicines/traditional medicines. It might 148 
especially be useful in developing countries, where approximately 80% of the population relies 149 
on herbal remedies (Neergheen-Bhujun 2013). However, more and more studies prove that even 150 
such herbs which have a long tradition can cause negative effects. For example, Haq (2004) in 151 
his review gives an extensive list of these herbs, which include ginkgo (Ginkgo biloba) and 152 
ginseng (Panax ginseng). Assessment of adverse effects is based on patients’ reports and/or 153 
animal toxicological tests. 154 
Adverse effects of alternative medicine have already been reported in Europe. Jacobsson 155 
et al. (2009) covered an approximately 20-year period (between 1987 and 2006) and found 967 156 
suspected adverse reactions related to different complementary and alternative medicine 157 
(CAM) products. Surprisingly, the most reported cases (8.1%) were connected to purple 158 
coneflower (Echinacea purpurea), an herb which is non-native in Hungary but is widely used. 159 
Medicinal herbs might also be used as Plant Food Supplements (PFS). In the framework of the 160 
European Project PlantLIBRA, a survey was performed involving over 2300 adults from 6 161 
countries (Finland, Germany, Italy, Romania, Spain and UK). Complaints regarding adverse 162 
reactions were also assessed. Causality was likely in 56 out of 87 cases (Restani et al. 2016). 163 
It is not the main intention of this paper to discuss all potentially toxic/hazardous plants 164 
included in the websites assessed in details. However, some plants are taken as examples. 165 
Comfrey (Symphytum officinale L., family Boraginaceae) is known to contain pyrrolizidine 166 
alkaloids (PAs) which have hepatotoxic effect. Allgaier and Franz (2015) review the regulations 167 
concerning the human exposure to PAs in herbal medicine products: in most cases, daily 168 
exposure is limited and/or the maximum period for its application is given (it is interesting to 169 
note, however, that the EMA public statement (EMA 2014) does not discriminate between oral 170 
and dermal exposure). As the above mentioned list of the Hungarian National Institute of 171 
Pharmacy and Nutrition (OÉTI 2013) clearly prohibits its use, we assessed how reliable 172 
information is given by the websites presented in this study. Of the 30 websites, 18 included 173 
comfrey and 5 provided misleading information.  174 
The use of another potentially hepatotoxic plant, greater celandine (Chelidonium majus 175 
L.) was causally related to liver injury according to European case reports (Teschke et al. 2012a) 176 
and hepatitis (Moro et al. 2009). All these authors emphasize that concern should be increased 177 
about the safety of oral use of C. majus. In our study, the plant was included in 12 websites, 7 178 
of them gave proper warning. In general, reported cases of herbal hepatotoxicity are the most 179 
often discussed and reviewed (Ernst 2003, Teschke et al. 2012b, Stickel and Shouval 2015) 180 
Another example is St. John’s wort (Hypericum perforatum) which was included in 181 
most of the websites, 25. Roughly 50% (13) gave proper safety instructions. The plant is most 182 
valued for treating depression and other mood disorders; exact modes of action are reviewed 183 
by Klemow et al. 2011. The main active compound is the photodynamic active plant pigment 184 
hypericin.  Phototoxic symptoms (“hypericism”) have been observed in grazing animals 185 
consuming large amounts of St. John’s wort, however, standard dosage used in case of mood 186 
disorders  does not produce phototoxic symptoms in humans (Schempp et al. 2002).  187 
In addition to its antidepressant capacity, St. John's wort is used for the topical treatment 188 
of superficial wounds such as scars and burns. Schempp et al. (2000) assessed the 189 
photosensitizing capacity of topical application of Hypericum oil (hypericin 110 μg/mL) and 190 
Hypericum ointment (hypericin 30 μg/mL) on volunteers. While no severe phototoxic potential 191 
was demonstrated, an increase of the erythema-index could be detected following the treatment 192 
with the Hypericum oil.  193 
 However, clinical trials prove that much higher risk is posed by the plant via the 194 
interaction with certain drugs, affecting their systemic bioavailability (Izzo and Ernst 2001, 195 
Mills 2004). For example, reduced plasma concentration of antiretroviral and anticancer drugs 196 
was reported (Borelli and Izzo 2009).  197 
 Recognising the potential risks associated with the use of herbal medicinal products 198 
(HMPs), Directive 2004/24/EC was issued in the European Union (Knöss and Chinou 2012). 199 
Naturally, its main field is the regulation of the market of such products. The public can be 200 
informed about the safe use or potential risk of herbs and herbal products by Community herbal 201 
monographs, Community list entries or public statements (PS) (reviewed by Chinou 2014). 202 
Community monographs are issued by the Committee on Herbal Medicinal Products while 203 
Community list entries are published by European Commission. Both Monographs and List 204 
entries provide a final and complete assessment of the safety and traditional use, but 205 
Community list entries are regarded as legally binding (Peschel 2014).  Public statements have 206 
been published when the assessment could not be completed due to lack of data or safety issues 207 
emerged. For example, the PS on C. majus formulates the problems: gives chemical description 208 
of alkaloid content and also summarises reported adverse drug reactions. It also gives a 209 
conclusion, including the following statements: ’the benefit-risk assessment of oral use of 210 
Chelidonium majus is considered negative with respect to the establishment of a community 211 
monograph’ and ’Safer herbal medicinal products are available in the indication in question’ 212 
(HMPC, 2011b).  213 
As a conclusion, it has been revealed by our study that the websites evaluated showed 214 
very diverse credibility, so in case of any doubt it is strongly recommended for potential users 215 
to consult more than one sources of information. Elvin-Lewis (2001) in an excellent work 216 
(Should we be concerned about herbal remedies) summarises all potential risks and formulates 217 
some useful guidelines. These include, among others, the following points: “Be informed, seek 218 
out unbiased, scientific sources” and “Know benefits and risks and potential side effects”.  219 
On the other hand, however, websites and cellphone applications are flexible in a way 220 
that their content can be continuously reviewed and improved. It should be very important in 221 
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Table 1. List of hazardous plants which (1) were included in at least one of the websites 372 
accessed and (2) are included in the OETI List.  373 
 374 
Name of the plant Active ingredients responsible for potential hazard 
Acorus calamus asarone 
Adonis sp. cardenolide glycoside, adonitoxin 
Alkanna tinctoria pyrrolizidine alkaloids, likopsamin 
Angelica archangelica furocoumarins 
Arctostaphylos uva-ursi quinone, arbutin, metlarbutin 
Aristolochia sp. aristolochid acid and derivatives  
Artemisia absinthium α-thujone 
Asarum europaeum β-asarone 
Berberis vulgaris isoquinoline alkaloids, berberine 
Bryonia sp. cytotoxic cucurbitacin 
Chelidonium majus isoquinoline alkaloids, chelidonine, protopine 
Cimicifuga racemosa actein, 27-deoxi-actein, cimicifugoside 
Colchicum sp. alkaloids, colchicine 
Conium maculatum alkaloids: coniine, coniceine 
Convallaria majalis cardenolide glycosides, convallatoxin, convallozid 
Datura sp. tropane alkaloids: atropine, scopolamine 
Digitalis sp. cardenolide glycosides, digitoxin, lanatoside 
Dryopteris filix-mas phloroglucin derivatives 
Ephedra sp. phenilalkilaminalkaloids, ephedrine, norephedrine 
Euonymus sp. evonine type alkaloids, evonin; cardenolide, evonoside 
Euphorbia sp. tiglinane, ingenane and daphnane type phorbol esters 
Fumaria officinalis isoquinoline alkaloids, scoulerine, protopine 
Genista tinctoria alkaloids: anagirin, cytisine, sparteine; izoflavone, genistein 
Gratiola officinalis triterpene glykoside, graciozid; cucurbitacin 
Hedera helix saponins, α(alpha)-hederin 
Helleborus sp. alkaloids, celliamine, sprintilline; cardenolide glycoside, 
hellebrin; toxic saponins, helleborin 
Hyoscyamus sp. tropane alkaloids, hyoscyamine, scopolamine 
Hypericum perforatum naphtodiantrones, hypericin, pseudohypericin 
Leonorus cardiaca diterpenes of labdane skeleton lactones, leocardin; alkaloids 
Lycopodium clavatum alkaloids, lycopodin 
Melilotus officinalis coumarin 
Oenanthe sp. oenantotoxin, apiol, myristicin 
Paeonia officinalis - 
Petasites hybridus (un/) insaturated pyrrolizidine alkaloids 
Pulsatilla sp. protoanemonin, ranunculin 
Rhamnus frangula hydroxyanthraquinone, frangulin, glucofrangulin 
Scopolia sp. tropane alkaloids, atropine, scopolamine 
Senecio sp. (un/) insaturated pyrrolizidine alkaloids, senecionine 
Solanum dulcamara steroidal alkaloids and saponins 
Symphytum sp. pyrrolizidine alkaloids 
Taxus baccata diterpene pseudoalkaloids, taxine A and B 
Teucrium chamaedrys neo-clerodane, teucrium lactones 
Tussilago farfara pyrrolizidine alkaloids 
Veratrum album steroidal alkaloids , protoveratrin A and B 
Viscum album Viscum lectin I-III; viscotoxin 
 375 
Table 2.  Number of potentially hazardous plants per website (PH); number of potentially 376 
hazardous plants per website with missing/incorrect information on the potential hazard (PH-); 377 
number of protected species per website (PS); number of protected species per website with 378 
missing/incorrect information on the legal status (PS-); number of all taxa included; short 379 
description of the website. W1-W30: Websites 1-30; App1-App2: cellphone applications 1-2. 380 
 381 




W1 7 7 2 0 31 Advices in everyday health issues 
W2 10 0 5 3 102 Reliable relic of medical plants 
W3 2 1 0 0 15 Gives alternative medicine option 
W4 3 1 0 0 53 
List of herbs recommended for 
different illness 
W5 1 1 0 0 9 Helping in everyday health 
W6 23 3 10 2 183 
Herbs A-Z, application, therapy, 
property, cultivation 
W7 11 4 7 0 90 Collection of most important herbs 
W8 1 1 1 1 207 
Collection of herbs, herbal teas and 
spices 
W9 14 3 7 5 49 Showing the healing power of nature 
W10 9 9 4 2 10 Description of herbal products 
W11 7 7 2 0 31 
Suggests that ‘Every complaint can 
be cured by a herb’ 
W12 25 13 16 15 246 Lexicon of herbal plants 
W13 3 2 0 0 32 Introduction to the world of herbs 
W14 4 0 1 0 55 Herbal teas and promotion 
W15 6 8 0 0 49 General uses of herbs 
W16 11 5 3 3 109 Phytotherapy guide 
W17 23 0 1 0 119 Description of herbs 
W18 0 0 0 0 18 Description of herbs 
W19 5 2 4 3 170 Modern use of herbs 
W20 13 3 6 3 239 Description of herbs 
W21 1 1 0 0 53 Description of herbs 
W22 1 0 0 0 16 
The most common herbs around the 
house 
W23 17 10 7 0 73 Collection of herbs  
W24 7 4 3 1 72 
Schematic overview of herbs, herbs 
and edible (wild) plants 
W25 4 0 0 0 23 Description of herbs 
W26 14 5 4 4 99 Effects of herbs 
W27 3 1 0 0 94 Description of herbs 
W28 38 25 18 17 240 Description of herbs 
W29 32 18 21 1 796 General uses of herbs 
W30 24 5 13 2 700 Description of herbs 
App1 22 6 3 1 187 Description of herbs 
App2 6 0 2 0 183 Description of herbs 
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